Specific adoptive immunotherapy: experimental basis and future potential.
D000818:Animals; D000950:Antigens, Ly / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003602:Cytotoxicity, Immunologic; D004195:Disease Models, Animal; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D007376:Interleukin-2 / Q000096:biosynthesis / Q000502:physiology; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000628:therapy*; D051379:Mice; D051381:Rats; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology / Q000637:transplantation*
D000950:Antigens, Ly; D007376:Interleukin-2; D003520:Cyclophosphamide